Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Novel therapies in respiratory management].

Revue medicale suisse - 27 Jan 2021

Schmit Aline, Guerreiro Ivan, Plojoux Jérôme, Janssens Jean-Paul, Adler Dan

Abstract excerpt

In this review of the recent medical literature, we have identified 4 topics of interest for the readers of Revue Médicale Suisse. Use of antifibrotic drugs in interstitial lung diseases will soon be extended to a phenotype labeled « progressive fibrosing interstitial lung disease » (PF-ILD). While awaiting for evidence-based treatment, consensual recommendations for a treatment algorithm in pulmonary sarcoidosis...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Disease Progression
Share to Lung Diseases, Interstitial
Share to Phenotype

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Pulmonary Fibrosis

Share to Switzerland

Source

Identifiers

PMID: 33507663

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Novel therapies in respiratory management].PMID 33507663Read ↗

[SEPAR (Spanish Society of Pneumology and Thoracic Surgery) Guidelines. Guideline for diagnosis and treatment of respiratory involvements in cystic fibrosis].Semantic proximity Read ↗

[Cystic fibrosis. Evidence based respiratory medicine: 2nd update workshop of the SPLF].Semantic proximity Read ↗

New and existing pharmacotherapeutic options for persistent asthma and COPD.Semantic proximity Read ↗

Novel mechanisms and treatment of idiopathic pulmonary fibrosis.Semantic proximity Read ↗

[PERSONALIZED MEDICINE: CHRONIC OBSTRUCTIVE PULMONARY DISEASE TREATMENT].Semantic proximity Read ↗

[THE JRS GUIDELINES FOR THE MANAGEMENT OF RETRACTORY ASTHMA: MOVING TOWARD PRECISION MEDICINE].Semantic proximity Read ↗

[Current treatment of chronic obstructive pulmonary disease].Semantic proximity Read ↗

Recent advances in understanding and treating COPD related to α1-antitrypsin deficiency.Semantic proximity Read ↗

Chronic obstructive pulmonary disease: diagnosis and treatment of stable phase of disease; personalized treatment approach using phenotype features of the disease Summary of the 2020-2021 Czech Pneumological and Phthiseological Society position paper.Semantic proximity Read ↗

Chronic obstructive pulmonary disease - diagnosis and management of stable disease; a personalized approach to care, using the treatable traits concept based on clinical phenotypes. Position paper of the Czech Pneumological and Phthisiological Society.Semantic proximity Read ↗

[How i treat a patient with idiopathic pulmonary fibrosis].Semantic proximity Read ↗

[Asthma-COPD overlap syndrome].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.